Press Releases

 

All Releases | Reset Search
Acquisitions | Business/Product | Corporate | Financial

2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008
DateTitle 
12/30/14Hospira Receives U.S. FDA Approval of Proprietary Analgesic Dyloject™(diclofenac sodium) InjectionPrinter Friendly Version
12/19/14Hospira to Present at the J.P. Morgan 33rd Annual Healthcare Conference Jan. 14, 2015Printer Friendly Version
12/19/14Hospira Foundation Announces the Leukemia & Lymphoma Society as Winner of $100,000 (Mission: Care)2 GrantPrinter Friendly Version
12/02/14Hospira Foundation Announces 10 Recipients of (Mission: Care)2 Grants and Initiates Next Phase of ChallengePrinter Friendly Version
11/17/14Hospira Mourns Passing of Founding Board Member Dr. Connie R. CurranPrinter Friendly Version
11/06/14Hospira Reports Third-Quarter 2014 ResultsPrinter Friendly Version
11/05/14Hospira Announces U.S. Launch of Generic Paricalcitol InjectionPrinter Friendly Version
10/06/14Hospira to Host Conference Call for Third-Quarter 2014 ResultsPrinter Friendly Version
10/02/14Hospira Foundation Announces Launch of (Mission: Care)2 Grant Challenge in Honor of 10th AnniversaryPrinter Friendly Version
08/15/14Hospira to Present at the Morgan Stanley Global Healthcare ConferencePrinter Friendly Version
07/30/14Hospira Reports Second-Quarter 2014 ResultsPrinter Friendly Version
07/04/14Hospira Completes Acquisition of Orchid's Active Pharmaceutical Ingredient Manufacturing and R&D FacilityPrinter Friendly Version
07/01/14Hospira to Host Conference Call for Second-Quarter 2014 ResultsPrinter Friendly Version
06/25/14Hospira Applauds Massachusetts Governor’s Signing of Biosimilars LegislationPrinter Friendly Version
05/30/14Hospira Applauds Delaware Governor’s Signing of Biosimilars LegislationPrinter Friendly Version
05/07/14Hospira Convenes Its 2014 Annual Meeting of ShareholdersPrinter Friendly Version
04/30/14Hospira Reports First-Quarter 2014 ResultsPrinter Friendly Version
04/22/14Hospira to Present at Upcoming Investor ConferencesPrinter Friendly Version
03/31/14Hospira to Host Conference Call for First-Quarter 2014 ResultsPrinter Friendly Version
03/27/14Hospira's TheraDoc™ Infection Control Assistant™ Ranked #1 in Its Category by KLAS for Second Consecutive YearPrinter Friendly Version
03/26/14Centre Corporatif Broccolini Saint-Laurent 2 : Les Travaux De Construction Sont LancésPrinter Friendly Version
03/26/14Broccolini Corporate Center Saint-Laurent 2: Construction Is UnderwayPrinter Friendly Version
03/26/14Hospira Applauds Indiana Governor’s Signing of Biosimilars LegislationPrinter Friendly Version
03/04/14Hospira Names David J. Endicott President of Medical DevicesPrinter Friendly Version
02/12/14Hospira Reports Fourth-Quarter and Full-Year 2013 ResultsPrinter Friendly Version
02/10/14Hospira to Present at Upcoming Investor ConferencesPrinter Friendly Version
01/09/14Hospira to Host Conference Call for Fourth-Quarter 2013 Results and 2014 ProjectionsPrinter Friendly Version